The pharmaceutical industry is continually challenged by high attrition rates (> 90 %) as drug candidates progress from discovery, through clinical trials and to ...

In the dynamic world of drug discovery and development, where the quest for innovative and effective therapies is relentless, peptide therapeutics have emerged as a ...

Immunotherapy has revolutionised the treatment of cancer. However, while it shows high efficacy against certain tumours, immunotherapy is not effective against all t...

Cancer is inherently difficult to detect and treat. To add to this complication, some patients develop drug resistance to treatment, leading to tumour recurrence or ...

In drug discovery, a technological shift is underway, promising to transform how we develop new medications and advance precision medicine. At the core of this trans...

 The development of biopharmaceuticals is expanding at an unprecedented rate, as the industry now comprises around 20 percent of the global pharmaceutical marke...

Viral vectors are a crucial tool within the advanced therapy sector, providing an elegant solution for gene delivery in areas such as gene therapy and vaccine develo...

Developing drug-device combination products for rare diseases presents unique challenges and opportunities for biopharmaceutical companies. These advanced drug deliv...

Complex biologics and next-generation cell and gene therapies demand precision handling to maintain stability and promote optimised and patient centric clinical tria...

Over the past few months, I’ve had numerous conversations at work and conferences about particulates in cell and gene therapies. These discussions have highlighted t...